Interruption of nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B - a new concept to achieve HBsAg reduction?

Siederdissen C. Hoener Zu; Rinker F.; Falk C. S.; Filmann N.; Maasoumy B.; Deterding K.; Port K.; Herrmann E.; Wedemeyer H.; Manns M. P.; Kraft A. R.; Cornberg M.

首页> 外文期刊>Journal of viral hepatitis. >Interruption of nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B - a new concept to achieve HBsAg reduction?

【24h】

Interruption of nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B - a new concept to achieve HBsAg reduction?

机译：中断HBeAg阴性慢性乙型肝炎的核苷酸类似物治疗-实现降低HBsAg的新概念吗？

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of viral hepatitis. 》 |2015年第2期| 共1页
作者
Siederdissen C. Hoener Zu; Rinker F.; Falk C. S.; Filmann N.; Maasoumy B.; Deterding K.; Port K.; Herrmann E.; Wedemeyer H.; Manns M. P.; Kraft A. R.; Cornberg M.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类传染病 ;
关键词

相似文献

外文文献
中文文献
专利

1. Interruption of nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B - a new concept to achieve HBsAg reduction? [J] . Siederdissen C. Hoener Zu, Rinker F., Falk C. S., Journal of viral hepatitis. . 2015 ,第Suppla2期

机译：中断HBeAg阴性慢性乙型肝炎的核苷酸类似物治疗-实现降低HBsAg的新概念吗？
2. Hepatitis B virus-specific T cell responses after stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B [J] . Rinker Franziska, Zimmer Christine L., zu Siederdissen Christoph Hoener, Journal of Hepatology: The Journal of the European Association for the Study of the Liver . 2018 ,第3期

机译：乙型肝炎病毒特异性T细胞应答在HBEAG阴性慢性乙型肝炎中止核（T）IDE模拟治疗后
3. HbsAg decline and HbsAg seroclearance in chronic hepatitis B patients on nucleos(t)ide analogues or pegylated interferon therapy a systematic review and model-based meta-analysis [J] . Slaets Leen, Verbinnen Thierry, Beumont Maria, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2017 ,第Suppla1期

机译：HBsAg下降和HBsAG血管菌在核乙型肝炎患者核核苷酸（T）IDE类似物或聚乙二醇化干扰素治疗中的系统审查和基于模型的荟萃分析
4. SYNTHESIS OF NEW NUCLEOS(T)IDE ANALOGUES AND EVALUATION OF THEIR CHOLINESTERASE INIBITORY ACTIVITIES [C] . Eduardo C. de Sousa, Margarida P. Pereira, Arben Berisa International Carbohydrate Symposium . 2018

机译：新核心（T）IDE类似物的合成及其胆碱酯酶内部活动的评价
5. Incidence, Durability, and Clinical Outcomes of Hepatitis B Surface Antigen Seroclearance in Patients with Chronic Hepatitis B [D] . Yip, Cheuk Fung. 2019

机译：慢性乙型肝炎患者乙型肝炎表面抗原血管疮的发病率，耐久性和临床结果
6. Kinetics and Prediction of HBsAg Loss during Long-Term Therapy with Nucleos(t)ide Analogues of Different Potency in Patients with Chronic Hepatitis B [O] . Min-Ran Li, Hong-Li Xi, Qin-Huan Wang, -1

机译：慢性乙型肝炎患者长期用不同效价的核苷类似物治疗期间HBsAg丢失的动力学和预测
7. Serum HBsAg Decline During Long-term Potent Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B and Prediction of HBsAg Loss [O] . Roeland Zoutendijk, Bettina E. Hansen, Anneke J. van Vuuren, 2011

机译：血清HBsAg期间的长期有效核（T）IDE模拟治疗慢性乙型肝炎和HBsAg损失预测

Interruption of nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B - a new concept to achieve HBsAg reduction?

著录项

相似文献

相关主题

期刊订阅